Apple had been oddly silent about the blood oxygen feature removed from its Apple Watch models sold in the US until now.

In today’s CEO Daily: Diane Brady talks to Joe Kiani, late of Masimo, who has just become the CEO of Like Minded Labs. The ...

Apple is urging a U.S. court to undo a trade decision that blocked imports of the Apple Watch because of the blood-oxygen ...

Apple is trying to appeal the ban on its blood oxygen sensor again. The company hasn't offered the feature since 2024.

Apple appeared before court in an effort to overturn a ruling that blocked U.S. sales of Apple Watches with blood-oxygen ...

Masimo (NASDAQ: MASI), a global medical technology company that develops and manufactures innovative noninvasive monitoring solutions, has joined the American Heart Association Center for Health ...

BD has appointed Bilal Muhsin executive vice president and president of its future Connected Care segment, effective ...

Apple asked a U.S. appeals court on Monday to overturn a trade tribunal's decision which forced it to remove blood-oxygen reading technology from its Apple Watches, in order to avoid a ban on its U.S.

Apple hasn’t given up on its legal battle to restore the blood oxygen sensor to the Apple Watch in the United States. Today, ...

Apple has asked a U.S. federal appeals court to overturn an import ban on Apple Watch models with blood oxygen monitoring ...

Apple asked the US Court of Appeals to overturn a 2023 ITC ruling that banned imports of Apple Watches with blood-oxygen ...

Buying $100 In MASI: If an investor had bought $100 of MASI stock 10 years ago, it would be worth $421.06 today based on a price of $162.98 for MASI at the time of writing.